TREATMENT OF SUPERIOR VENA-CAVA THROMBOSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR

被引：23
|
作者：
GREENBERG, S
KOSINSKI, R
DANIELS, J
机构：
[1] MONMOUTH MED CTR,DIV CARDIOL,LONG BRANCH,NJ 07740
[2] MONMOUTH MED CTR,DIV HEMATOL MED ONCOL,LONG BRANCH,NJ 07740
来源：
CHEST | 1991年 / 99卷 / 05期
关键词：
D O I：
10.1378/chest.99.5.1298
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Thrombotic occlusion of the superior vena cava is an uncommon but serious complication of chronic indwelling venous catheters. Several reports have shown thrombolytic therapy with intravenous streptokinase or urokinase to be effective in the treatment of this condition. We report a case of superior vena cava thrombosis in a 53-year-old woman receiving chemotherapy for breast carcinoma through a subcutaneously implanted venous access catheter who was successfully treated with peripheral infusion of recombinant tissue type plasminogen activator (rtPA).
引用
收藏
页码：1298 / 1301
页数：4
相关论文
共 50 条
  • [21] EXTENDED DEEP-VEIN AND INFERIOR VENA-CAVA THROMBOSIS IN A 15-YEAR-OLD BOY - SUCCESSFUL LYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR 2 WEEKS AFTER ONSET OF SYMPTOMS
    ROSENBAUM, T
    RAMMOS, S
    KNIEMEYER, HW
    GOBEL, U
    EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (12) : 978 - 980
  • [22] THE ROLE OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN THE TREATMENT OF ACUTE PULMONARY THROMBOEMBOLISM
    YAMASAWA, F
    OKADA, Y
    ASANO, K
    MORI, M
    FUJITA, H
    HASEGAWA, N
    AOKI, T
    ISHIZAKA, A
    KANAZAWA, M
    KAWASHIRO, T
    INTERNAL MEDICINE, 1992, 31 (07) : 885 - 888
  • [23] SUCCESSFUL TREATMENT OF HEMOLYTIC-UREMIC SYNDROME WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    KRUEZ, W
    LINDE, R
    BECKER, S
    SEIFRIED, E
    LANCET, 1993, 341 (8861): : 1665 - 1666
  • [24] RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND HEPARIN IN ACUTE ANGINA AT REST
    SCRUTINIO, D
    BIASCO, MG
    RIZZON, P
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 53 (06): : 665 - 676
  • [25] ACTIVATION OF PROTHROMBIN ACCOMPANYING THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    EISENBERG, PR
    SOBEL, BE
    JAFFE, AS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (05) : 1065 - 1069
  • [26] Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis
    Tan, H
    Kizilkaya, M
    Alper, F
    Becit, N
    Kürsat, H
    ACTA PAEDIATRICA, 2005, 94 (02) : 239 - 241
  • [27] EXTRAHEPATIC METABOLISM OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) IN DOGS
    FONG, KLL
    BOYLE, KE
    CRYSLER, CS
    LANDI, MS
    GRIFFIN, HE
    LYNN, RK
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 435 - 435
  • [28] POSTTRANSLATIONAL MODIFICATION OF THE FREE SULFHYDRYL OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    COX, ET
    GUNSON, JV
    SLIWKOWSKI, MB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 31 - BIOT
  • [29] RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - PHARMACOKINETICS AND INTERACTION WITH THE FIBRINOLYTIC SYSTEM
    SEIFRIED, E
    BOCK, F
    TANSWELL, P
    RIJKEN, DC
    KLUFT, C
    HEIMPEL, H
    KLINISCHE WOCHENSCHRIFT, 1988, 66 : 40 - 49
  • [30] THROMBOLYTIC EFFECT OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR ADMINISTERED AS A BOLUS
    CERCEK, B
    LEW, AS
    YANO, J
    REDDY, KNN
    GANZ, W
    CLINICAL RESEARCH, 1987, 35 (01): : A102 - A102
12345